Benitec Biopharma Inc. 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-222885
- Form type
- 10-Q
- CIK
- 0001808898
- Primary document
- https://www.sec.gov/Archives/edgar/data/1808898/000119312526222885/bntc-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Benitec Biopharma Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-36.8M | - | - |
| Net Income | $-32.7M | - | - |
| Eps Basic | -0.72 | - | - |
| Eps Diluted | -0.72 | - | - |
| Cash And Equivalents | $184.8M | - | - |
| Total Assets | $187.0M | - | - |
| Total Liabilities | $3.7M | - | - |
| Shareholders Equity | $183.3M | - | - |
| Operating Cash Flow | $-11.6M | - | - |
| Capital Expenditures | $26,000 | - | - |